Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Long-term results of the "liver first" approach in patients with locally advanced rectal cancer and synchronous liver metastases.

Ayez N, Burger JW, van der Pool AE, Eggermont AM, Grunhagen DJ, de Wilt JH, Verhoef C.

Dis Colon Rectum. 2013 Mar;56(3):281-7. doi: 10.1097/DCR.0b013e318279b743.

PMID:
23392140
2.

The "liver-first approach" for patients with locally advanced rectal cancer and synchronous liver metastases.

Verhoef C, van der Pool AE, Nuyttens JJ, Planting AS, Eggermont AM, de Wilt JH.

Dis Colon Rectum. 2009 Jan;52(1):23-30. doi: 10.1007/DCR.0b013e318197939a.

PMID:
19273952
3.

Locally advanced mid/low rectal cancer with synchronous liver metastases.

Viganò L, Karoui M, Ferrero A, Tayar C, Cherqui D, Capussotti L.

World J Surg. 2011 Dec;35(12):2788-95. doi: 10.1007/s00268-011-1272-7.

PMID:
21947493
4.

Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.

Arredondo J, Baixauli J, Beorlegui C, Arbea L, Rodríguez J, Sola JJ, Chopitea A, Hernández-Lizoáin JL.

Dis Colon Rectum. 2013 Apr;56(4):416-21. doi: 10.1097/DCR.0b013e318274d9c6.

PMID:
23478608
5.

Stage IV rectal cancer with liver metastases: is there a benefit to resection of the primary tumor?

Cellini C, Hunt SR, Fleshman JW, Birnbaum EH, Bierhals AJ, Mutch MG.

World J Surg. 2010 May;34(5):1102-8. doi: 10.1007/s00268-010-0483-7.

PMID:
20177683
6.

FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation.

Ruby JA, Leibold T, Akhurst TJ, Shia J, Saltz LB, Mazumdar M, Riedel ER, Larson SM, Guillem JG.

Dis Colon Rectum. 2012 Apr;55(4):378-86. doi: 10.1097/DCR.0b013e318244a666.

PMID:
22426260
7.

Neoadjuvant chemotherapy and primary-first approach for rectal cancer with synchronous liver metastases.

Gall TM, Basyouny M, Frampton AE, Darzi A, Ziprin P, Dawson P, Paraskeva P, Habib NA, Spalding DR, Cleator S, Lowdell C, Jiao LR.

Colorectal Dis. 2014 Jun;16(6):O197-205. doi: 10.1111/codi.12534.

PMID:
24344746
8.

Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis.

Pasetto LM, Friso ML, Pucciarelli S, Basso U, Toppan P, Rugge M, Sinigaglia G, Nitti D, Sotti G, Monfardini S.

Anticancer Res. 2007 Mar-Apr;27(2):1079-85.

9.

Treatment strategy for rectal cancer with synchronous metastasis: 65 consecutive Italian cases from the Bologna Multidisciplinary Rectal Cancer Group.

Pinto C, Pini S, Di Fabio F, Cuicchi D, Iacopino B, Lecce F, Ercolani G, Rojas Llimpe FL, De Raffele E, Stella F, Di Tullio P, Giaquinta S, Pinna AD, Cola B.

Oncology. 2014;86(3):135-42. doi: 10.1159/000357782. Epub 2014 Feb 6.

PMID:
24504268
10.

Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer.

Rödel C, Grabenbauer GG, Matzel KE, Schick C, Fietkau R, Papadopoulos T, Martus P, Hohenberger W, Sauer R.

Dis Colon Rectum. 2000 Mar;43(3):312-9.

PMID:
10733111
11.

Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases.

van der Pool AE, de Wilt JH, Lalmahomed ZS, Eggermont AM, Ijzermans JN, Verhoef C.

Br J Surg. 2010 Mar;97(3):383-90. doi: 10.1002/bjs.6947.

PMID:
20101594
12.

'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases.

Mentha G, Roth AD, Terraz S, Giostra E, Gervaz P, Andres A, Morel P, Rubbia-Brandt L, Majno PE.

Dig Surg. 2008;25(6):430-5. doi: 10.1159/000184734. Epub 2009 Feb 12.

PMID:
19212115
13.

Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcome.

Mezhir JJ, Shia J, Riedel E, Temple LK, Nash GM, Weiser MR, Paty PB, Wong WD, Guillem JG.

Ann Surg. 2012 Aug;256(2):274-9. doi: 10.1097/SLA.0b013e31825c13d5.

PMID:
22791103
14.

Response to neoadjuvant therapy in patients with early age-of-onset rectal cancer.

Steinhagen E, Shia J, Riedel E, Nash GM, Weiser MR, Temple LK, Paty PB, Guillem JG.

Dis Colon Rectum. 2013 Jan;56(1):58-63. doi: 10.1097/DCR.0b013e3182707e47.

PMID:
23222281
15.

Liver metastases from breast cancer: long-term survival after curative resection.

Selzner M, Morse MA, Vredenburgh JJ, Meyers WC, Clavien PA.

Surgery. 2000 Apr;127(4):383-9.

PMID:
10776428
16.

Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rödel C.

J Clin Oncol. 2012 Jun 1;30(16):1926-33. doi: 10.1200/JCO.2011.40.1836. Epub 2012 Apr 23.

17.

Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases.

Chiappa A, Bertani E, Makuuchi M, Zbar AP, Contino G, Viale G, Pruneri G, Bellomi M, Della Vigna P, Zampino MG, Fazio N, Travaini ML, Trifirò G, Corbellini C, Andreoni B.

Hepatogastroenterology. 2009 May-Jun;56(91-92):829-34.

PMID:
19621711
18.
19.

Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes.

Leroy J, Jamali F, Forbes L, Smith M, Rubino F, Mutter D, Marescaux J.

Surg Endosc. 2004 Feb;18(2):281-9. Epub 2003 Dec 29. Review.

PMID:
14691716
20.

Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer.

Huh JW, Kim HR, Kim YJ.

Dis Colon Rectum. 2013 Jun;56(6):698-703. doi: 10.1097/DCR.0b013e3182837e5b.

PMID:
23652742
Items per page

Supplemental Content

Write to the Help Desk